FluoroPharma Medical, Inc.
FPMI
$0.0001
$0.000.00%
OTC PK
| 12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -31.41% | -22.09% | -25.84% | -28.75% | -27.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.88% | -30.48% | -30.68% | -37.48% | -38.36% |
| Operating Income | 30.88% | 30.48% | 30.68% | 37.48% | 38.36% |
| Income Before Tax | 35.21% | -78.46% | -19.24% | -23.21% | 23.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 35.21% | -78.46% | -19.24% | -23.21% | 23.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.21% | -78.46% | -19.24% | -23.21% | 23.41% |
| EBIT | 30.88% | 30.48% | 30.68% | 37.48% | 38.36% |
| EBITDA | 31.26% | 30.78% | 30.87% | 37.78% | 38.75% |
| EPS Basic | 37.48% | -42.54% | -3.96% | -11.37% | 24.97% |
| Normalized Basic EPS | 68.36% | -26.32% | 16.83% | 5.59% | 22.41% |
| EPS Diluted | 34.09% | -47.76% | -3.96% | -11.37% | 24.97% |
| Normalized Diluted EPS | 63.86% | -34.47% | 16.83% | 5.59% | 22.41% |
| Average Basic Shares Outstanding | 11.71% | 12.00% | 9.41% | 6.44% | 4.89% |
| Average Diluted Shares Outstanding | 47.11% | 48.14% | 9.41% | 6.44% | 4.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |